Buprenorphine in the Intensive Care Unit: Commentary on the Unanswered Questions
The removal of the X-waiver in the Mainstreaming Addiction Treatment (MAT) Act of 2023
has substantial implications for buprenorphine prescribing as one of the options to treat …
has substantial implications for buprenorphine prescribing as one of the options to treat …
Buprenorphine: Its Emerging Role as a Strategy to Reduce Full Opioid Agonist Use in the ICU
JW Devlin - Critical Care Medicine, 2023 - journals.lww.com
Dr. Devlin received funding from the National Institute on Aging, the Agency for Healthcare
Research and Quality, Sedana Medical, and BioXcel Therapeutics; he disclosed he served …
Research and Quality, Sedana Medical, and BioXcel Therapeutics; he disclosed he served …
[HTML][HTML] Buprenorfina jako unikalny analgetyk opioidowy–przegląd danych eksperymentalnych i klinicznych
P Dębowska, A Przeklasa-Muszyńska, M Kocot-Kępska - Ból, 2024 - bolczasopismo.pl
Buprenorfina jest lekiem stosowanym w medycynie bólu od kilku dekad, jednak w ostatnich
latach jest ponownie odkrywana ze względu na unikalny profil receptorowy i …
latach jest ponownie odkrywana ze względu na unikalny profil receptorowy i …
[HTML][HTML] Buprenorphine as a unique opioid analgesic–an overview of experimental and clinical data
P Dębowska, A Przeklasa-Muszyńska, M Kocot-Kępska - Ból, 2024 - bolczasopismo.pl
Buprenorphine has been used in pain medicine for several decades, but in recent years it
has been rediscovered due to its unique receptor and pharmacokinetic profile. The well …
has been rediscovered due to its unique receptor and pharmacokinetic profile. The well …
Endogenous opiates and behavior: 2023
RJ Bodnar - Peptides, 2024 - Elsevier
This paper is the forty-sixth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …
research concerning the endogenous opioid system, summarizing articles published during …